tiprankstipranks
Trending News
More News >
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Ratios

Compare
88 Followers

Design Therapeutics Ratios

DSGN's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, DSGN's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
29.31 29.58 31.10 72.96 15.55
Quick Ratio
29.31 29.58 31.20 72.72 15.50
Cash Ratio
2.67 2.20 2.46 56.52 1.02
Solvency Ratio
-4.96 -5.55 -4.21 -4.20 -0.17
Operating Cash Flow Ratio
-5.09 -6.09 -4.76 -5.56 -3.72
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 238.04M$ 272.63M$ 321.29M$ 377.01M$ -11.60M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.01 <0.01 0.00
Debt-to-Equity Ratio
<0.01 0.01 0.01 <0.01 0.00
Debt-to-Capital Ratio
<0.01 0.01 0.01 <0.01 0.00
Long-Term Debt-to-Capital Ratio
<0.01 0.00 <0.01 <0.01 0.00
Financial Leverage Ratio
1.04 1.04 1.04 1.02 -3.23
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 0.00
Interest Debt Per Share
0.03 0.05 0.07 0.08 0.00
Net Debt to EBITDA
0.34 0.27 0.36 8.26 0.29
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%-2112.39%
EBIT Margin
0.00%0.00%0.00%0.00%-3663716.81%
EBITDA Margin
0.00%0.00%0.00%0.00%-3683628.32%
Operating Profit Margin
0.00%0.00%0.00%0.00%-3685840.71%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-3663716.81%
Net Profit Margin
0.00%0.00%0.00%0.00%-3663716.81%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-3663716.37%
Net Income Per EBT
100.00%100.00%92.59%100.00%100.00%
EBT Per EBIT
79.49%85.51%93.66%99.17%99.40%
Return on Assets (ROA)
-19.67%-23.08%-17.18%-9.10%-22.67%
Return on Equity (ROE)
-20.48%-24.08%-17.91%-9.30%73.18%
Return on Capital Employed (ROCE)
-25.61%-27.92%-20.46%-9.30%-24.37%
Return on Invested Capital (ROIC)
-25.61%-27.85%-18.91%-9.26%-23.77%
Return on Tangible Assets
-19.67%-23.08%-17.18%-9.10%-22.67%
Earnings Yield
-14.20%-45.07%-10.26%-3.61%-0.73%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.02
Payables Turnover
0.00 0.28 0.15 0.08 <0.01
Inventory Turnover
0.00 0.00 -0.42 0.10 0.05
Fixed Asset Turnover
0.00 0.00 0.00 0.00 <0.01
Asset Turnover
0.00 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 <0.01
Cash Conversion Cycle
0.00 -1.32K -3.24K -1.04K -78.17K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 16.15K
Days of Inventory Outstanding
0.00 0.00 -873.34 3.55K 7.81K
Days of Payables Outstanding
0.00 1.32K 2.37K 4.58K 102.13K
Operating Cycle
0.00 0.00 -873.34 3.55K 23.96K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.76 -1.05 -0.92 -0.64 -0.32
Free Cash Flow Per Share
-0.77 -1.05 -0.94 -0.67 -0.32
CapEx Per Share
<0.01 <0.01 0.02 0.03 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.02 1.05 1.01
Dividend Paid and CapEx Coverage Ratio
-126.78 -228.75 -55.90 -19.10 -114.07
Capital Expenditure Coverage Ratio
-126.78 -228.75 -55.90 -19.10 -114.07
Operating Cash Flow Coverage Ratio
-28.10 -19.20 -13.90 -8.09 0.00
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 -38.36K
Free Cash Flow Yield
-12.44%-39.64%-9.14%-3.14%-0.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.04 -2.22 -9.75 -27.68 -136.25
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 4.99M
Price-to-Book (P/B) Ratio
1.44 0.53 1.75 2.57 -99.70
Price-to-Free Cash Flow (P/FCF) Ratio
-8.04 -2.52 -10.94 -31.82 -129.00
Price-to-Operating Cash Flow Ratio
-8.10 -2.53 -11.14 -33.48 -130.13
Price-to-Earnings Growth (PEG) Ratio
0.27 -0.17 -0.27 -0.18 -0.46
Price-to-Fair Value
1.44 0.53 1.75 2.57 -99.70
Enterprise Value Multiple
-5.26 -1.96 -8.73 -19.29 -135.22
EV to EBITDA
-5.26 -1.96 -8.73 -19.29 -135.22
EV to Sales
0.00 0.00 0.00 0.00 4.98M
EV to Free Cash Flow
-7.55 -2.21 -10.51 -22.28 -128.73
EV to Operating Cash Flow
-7.61 -2.22 -10.69 -23.44 -129.86
Tangible Book Value Per Share
4.28 4.96 5.88 8.32 -0.42
Shareholders’ Equity Per Share
4.28 4.96 5.88 8.32 -0.42
Tax and Other Ratios
Effective Tax Rate
0.00 <0.01 0.07 <0.01 0.02
Revenue Per Share
0.00 0.00 0.00 0.00 <0.01
Net Income Per Share
-0.88 -1.19 -1.05 -0.77 -0.30
Tax Burden
1.00 1.00 0.93 1.00 1.00
Interest Burden
0.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 26.81K
SG&A to Revenue
0.00 0.00 0.00 0.00 11.04K
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 1.99K
Income Quality
0.87 0.88 0.81 0.83 1.05
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis